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The primarily neuronal RNA-binding protein HuD is
implicated in learning and memory. Here, we report
the identification of several HuD target transcripts
linked to Alzheimer’s disease (AD) pathogenesis.
HuD interacted with the 30 UTRs of APP mRNA
(encoding amyloid precursor protein) and BACE1
mRNA (encoding b-site APP-cleaving enzyme 1)
and increased the half-lives of these mRNAs. HuD
also associated with and stabilized the long noncod-
ing (lnc)RNA BACE1AS, which partly complements
BACE1 mRNA and enhances BACE1 expression.
Consistent with HuD promoting production of APP
and APP-cleaving enzyme, the levels of APP,
BACE1, BACE1AS, and Ab were higher in the brain
of HuD-overexpressing mice. Importantly, cortex
(superior temporal gyrus) from patients with AD
displayed significantly higher levels of HuD and,
accordingly, elevated APP, BACE1, BACE1AS, and
Ab than did cortical tissue from healthy age-matched
individuals. We propose that HuD jointly promotes
the production of APP and the cleavage of its amyloi-
dogenic fragment, Ab.INTRODUCTION
The posttranscriptional regulation of gene expression underlies
many aspects of mammalian physiology and pathology. The
two main groups of posttranscriptional regulators, RNA-binding
proteins (RBPs) and noncoding RNAs (Moore, 2005;Morris et al.,
2010), have been implicated in all steps controlling gene expres-
sion after transcription: pre-mRNA splicing and maturation, and
mRNA transport, editing, stability, storage, and translation.CAmong thenoncodingRNAs that control geneexpressionpost-
transcriptionally, the best-characterized molecules are micro-
RNAs (miRNAs; 22 nt in length), which typically associate with
the 30 UTR of target mRNAs and repress their translation and/or
stability (Fabian et al., 2010). Long noncoding RNAs (lncRNAs)
are also gaining recognition as posttranscriptional regulators of
gene expression. Through complementary basepairing, lncRNAs
can modulate the turnover and translation rate of target mRNAs;
in the absence of complementarity, lncRNAs can suppress pre-
cursormRNAsplicingand translationbyactingasdecoysorcom-
petitors of RBPs and miRNAs (Yoon et al., 2013).
RBPs associate with a wide range of coding and noncoding
RNAs and thus modulate many critical functions of the cell,
including proliferation, survival, differentiation, motility, senes-
cence, and apoptosis (Glisovic et al., 2008). Among them, the
elav (embryonic lethal abnormal vision)/Hu (human antigen)
group of proteins has been implicated primarily in controlling
the stability and translation of target mRNAs. The Hu family
comprises a ubiquitous member (HuR) and three predominantly
neuronal members (HuB, HuC, and HuD). Elav/Hu proteins
generally bind to U- and AU-rich RNA elements in target tran-
scripts with which they associate via three highly conserved
RNA recognitionmotifs (RRMs 1–3) (Hinman and Lou, 2008; Pas-
cale et al., 2008).
Unlike HuR, which is primarily nuclear, HuD is abundantly
present in the cytoplasm. HuD expression is restricted to a few
tissues, mainly neurons, gonads, and pancreatic b cells (Good,
1995, Lee et al., 2012). Several lines of evidence indicate that
in cultured neurons, HuD promotes neurite outgrowth (Kasa-
shima et al., 1999; Abdelmohsen et al., 2010), but the physiolog-
ical role of HuD in animals appears to be complex. Although adult
HuD-knockout (KO) mice do not exhibit morphological defects,
HuD-KO embryos display transient impairment in cranial nerve
development, and neurospheres derived from these mice
generate fewer neurons compared to wild-type (WT) mice (Aka-
matsu et al., 2005). At the same time, expression of HuB, HuC,
and HuD specifically increases in areas of mouse and rat brainell Reports 7, 1401–1409, June 12, 2014 ª2014 The Authors 1401
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associated with spatial learning, implicating these Hu proteins in
learning and memory. In these tissues, elevated HuD is associ-
ated with enhanced production of GAP-43 (growth-associated
protein-43), encoded by a HuD target mRNA (Anderson et al.,
2001; Pascale et al., 2004). The roles of HuD in neuronal develop-
ment and memory have been reviewed (Descheˆnes-Furry et al.,
2006; Pascale et al., 2008; Perrone-Bizzozero et al., 2011).
HuD targets include many mRNAs that encode proteins pref-
erentially expressed in neurons (e.g., GAP-43, acetylcholines-
terase, tau, PSD-95, neuroserpin, musashi-1, and HuD itself),
as well as proteins expressed in other tissues (e.g., c-Myc,
N-myc, RhoA, c-Fos, VEGF, p21, p27, Bcl-2, NCAM1, and
MARCKS) (Descheˆnes-Furry et al., 2006; Pascale et al., 2008;
Abdelmohsen et al., 2010; Bolognani et al., 2010). With the
exception of p27 and insulin, whose translation is repressed by
HuD (Kullmann et al., 2002; Lee et al., 2010), HuD generally pro-
motes the expression of target mRNAs. A recent survey of HuD
target transcripts in human neuroblastoma cells (Abdelmohsen
et al., 2010) revealed a number of HuD-interacting mRNAs impli-
cated in the synthesis and processing of amyloid precursor pro-
tein (APP) into its amyloidogenic fragment, Ab. HuD binds APP
mRNA and b-site APP-cleaving enzyme 1 (BACE1) mRNA, the
latter encoding the b-secretase that cleaves APP in the critical
first proteolytic-processing step that leads to the generation
of Ab. HuD also bound to and increased the abundance of
BACE1AS, a lncRNA that stabilizesBACE1mRNA and promotes
BACE1 expression (Faghihi et al., 2008). Our findings indicate
that HuD may coordinate the production and cleavage of APP
and further suggest that this regulatory paradigm contributes
to Alzheimer’s disease (AD) pathogenesis, characterized by the
accumulation of toxic aggregates of Ab peptide.
RESULTS
HuDAssociates withmRNAs Involved in APPProcessing
RNAs associated with HuD were identified by immunoprecipita-
tion (IP) of ribonucleoprotein (RNP) complexes (RIP analysis) withFigure 1. HuD Binds to APP 30 UTR and Enhances APP mRNA and Sta
(A) Analysis of HuD in SK-N-F1 cells following IP with IgG and anti-HuD and WB
weight (MW) markers are indicated.
(B) Limited analysis (using RIP) to survey HuD-interacting mRNAs encoding prot
levels in the IP materials were measured by RT-qPCR analysis, normalized to GA
relative to IgG IP.
(C) Top, schematic ofAPPmRNA, depicting the 50 UTR,CR, and 30 UTR, and thedif
downusing streptavidin beads; HuDwasdetected byWBanalysis. BiotinylatedGA
(D and E) Forty-eight hours after transfecting Ctrl or HuD siRNAs, the levels of pro
and the reduction in APP mRNA levels by RT-qPCR analysis (normalized to GAP
(F) Cells transfected as in (D) were treated with actinomycin D, and the levels ofAP
by RT-qPCR; the t1/2 of APP andGAPDHmRNAwere quantified by measuring the
relative to time 0 hr.
(G) Polysomes were prepared from cells transfected as in (D) by fractionating cytop
sedimentation. Theminus sign (‘‘’’) indicates no ribosomal components. Small (40
progressively largerpolysomes, ranging from low tohighmolecularweight (LMWand
of APP and GAPDHmRNAs was studied by RT-qPCR analysis of RNA in gradient
(H) Left, schematic of reporters prepared to analyze the influence ofAPP 30 UTRon
Ctrl or HuD siRNAs, cells were further transfected with psiCHECK2 or psiCHECK-
transfected plasmid and normalized to luciferase activity (RL/FL) in Ctrl siRNA (l
GAPDH mRNA, were quantified by RT-qPCR analysis and plotted relative to the
Graphs in (B), (E), (F), and (H) display the mean and SD from three independent e
Canti-HuD in parallel with control immunoglobulin G (IgG) IP. The
interaction of HuD in the IP material (Figure 1A) with bound RNAs
was assayed by reverse transcription (RT) and subsequent real-
time, quantitative PCR (qPCR) amplification. An earlier survey in
the human neuroblastoma BE(2)-M17 cells (Abdelmohsen et al.,
2010) revealed that APP mRNA was a potential target of HuD.
Experiments to investigate this possibility directly revealed that
APP mRNA was significantly enriched in HuD IP samples
compared with IgG IP samples and additionally showed that
several HuD-bound mRNAs encoded proteases that cleave
APP to generate Ab peptide. Among them, the BACE1 mRNA
was also significantly enriched, as previously observed by
Bolognani et al. (2010), whereas HuD associated less promi-
nently with mRNAs encoding components of the g-secretase
complex (PSEN1 and PSEN2 mRNAs, encoding presenilins,
and APH1A and APH1B mRNAs, encoding presenilin-stabiliza-
tion factors) (Figure 1B). The PEN2 mRNA (encoding presenilin
enhancer 2) and the NCSTN mRNA (encoding nicastrin, a
component of the g-secretase protein complex) showed no
significant enrichment in HuD IP (Figure 1B). We thus focused
on analyzing the interaction of HuDwithAPP andBACE1mRNAs
in human neuroblastoma SK-N-F1 cells.
To identify areas of interaction of HuD with APP mRNA,
biotinylated segments spanning the 50 UTR, coding region (CR)
and 30 UTR of the APPmRNAwere synthesized in vitro and incu-
bated with cytoplasmic lysates of SK-N-F1 cells. After pull-down
using streptavidin-coated beads, HuD association with the
biotinylated transcripts was assessed by western blot (WB)
analysis. As shown in Figure 1C, several APP 30 UTR segments
associated with HuD in vitro, but segments of the APP CR, the
APP 50 UTR, or a negative control RNA (glyceraldehyde 3-phos-
phate dehydrogenase [GAPDH] 30 UTR) did not. Although HuD
bound multiple APP 30 UTR segments, the most robust affinity
and regulation (Figure S1) were mapped to segment 30d. The
consequences of the interaction of HuD with the APP mRNA
were assessed by silencing HuD; 48 hr after transfecting SK-
N-F1 cells with a small interfering RNA (siRNA) directed tobility and Translation
analysis. HuD (arrowhead), immunoglobulin heavy chain (HC), and molecular
eins with roles in APP production or processing. Following IP as in (A), mRNA
PDH mRNA levels in each IP reaction, and represented as ‘‘Fold enrichment’’
ferent biotinylatedRNAsegments (gray lines) tested for binding toHuDafter pull-
PDH 30 UTRwas included as negative control ‘‘Input,’’ 20 mg ofwhole-cell lysate.
teins APP, HuD, and loading control b-actin were assessed byWB analysis (D),
DH mRNA levels) (E).
PmRNA andGAPDHmRNA (encoding a housekeeping protein) were assessed
time required for transcript levels to decline to 50% of their original abundance
lasmic extracts through sucrose gradients. The arrow indicates the direction of
S) and large (60S) ribosomal subunits andmonosomes (80S) in fractions 2–4, and
HMW,respectively) in fractions6–11are shown in the rightpanel. Thedistribution
fractions and is represented as percentage (%) of total RNA in the gradient (left).
gene expression. In the right panels, 12 hr after transfecting SK-N-F1 cells with
APP(30 UTR), and 24 hr later, luciferase activity was measured (RL/FL) for each
eft). RL mRNA and FL mRNA levels in each transfection group, normalized to
changes in the psiCHECK2 group (right).
xperiments. *p < 0.05.
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Figure 2. HuD Associates with BACE1
mRNA
(A) Top, schematic of BACE1 mRNA, indicating
the different biotinylated RNA segments (gray un-
derlines) that were prepared and tested for binding
to HuD after pull-down using streptavidin beads;
HuD was detected by WB analysis as explained in
Figure 1C.
(B–E) Forty-eight hours after transfecting SK-N-F1
cells with the siRNAs indicated, BACE1 mRNA
levels were measured by RT-qPCR analysis (*p <
0.05) (B), and the t1/2 of BACE1 mRNA (C) was
quantified as explained in Figure 1F. The levels of
BACE1 protein were assessed by WB analysis (D),
and the relative distribution of BACE1 mRNA on
polysomes (E) was studied as explained in Fig-
ure 1G.HuD, the decline in HuD levels caused a marked decrease in the
levels of APP andAPPmRNA, as assessed byWB and RT-qPCR
analyses, respectively (Figures 1D and 1E).
HuD Enhances the Stability and Translation of APP
mRNA
Because HuDwas shown to stabilize a number of target mRNAs,
we investigated if the loss in APPmRNA after silencing HuD was
due at least in part to changes in APP mRNA stability. After
silencing HuD expression in SK-N-F1 cells, actinomycin D was
used to inhibit de novo transcription; the time needed for APP
mRNA to be reduced to 50% of its initial abundance (its half-
life [t1/2]) was then calculated by measuring APP mRNA levels
using RT-qPCR and normalizing to 18S rRNA levels. As shown
in Figure 1F, APP mRNA t1/2 in control cells (Ctrl siRNA;
>6.0 hr) was much longer than that measured in HuD siRNA cells
(4.0 hr). The t1/2 ofGAPDHmRNA, a stablemRNA that encodes
a housekeeping protein, was not shortened by HuD silencing1404 Cell Reports 7, 1401–1409, June 12, 2014 ª2014 The Authors(Figure 1F). HuD was also shown to
promote mRNA translation (Fukao et al.,
2009); to investigate if HuD also affected
APP translation, we silenced HuD in SK-
N-F1 cells and quantified the fraction of
APP mRNA associated with the tran-
slation machinery in each transfection
group. Cytoplasmic extracts from the
Ctrl siRNA and HuD siRNA groups were
fractionated on sucrose gradients, and
the relative abundance of APP mRNA in
each fraction indicated the association
of APPmRNAwith the cellular polysomes
and hence its translation status. The
polysome-fractionation pattern was
identical in both groups, suggesting
that silencing HuD does not affect tran-
slation globally. In Ctrl siRNA cells, APP
mRNA levels were very low in nontran-
slating and low-translating fractions of
the gradient (fractions 1–4, where free
RNA and 40S and 60S subunits, aswell as 80S monosomes, are found), but they were abundant
in the actively translating fractions of the gradient (fractions
5–10, spanning low and high molecular weight polysomes)
(Figure 1G) and peaking at fraction 9. However, in HuD siRNA-
transfected cells, APP mRNA showed a leftward shift on
the gradient, peaking at fraction 8, indicating that APP
mRNA formed on average smaller polysomes after silencing
HuD. These results agree with a role for HuD both elevating
APP mRNA abundance and enhancing the translation of APP
mRNA.
These effects were further examined using heterologous lucif-
erase reporter vectors that expressed Renilla luciferase (RL)
lacking or containing the APP 30 UTR (psiCHECK2 or psi-
CHECK2-APP[30 UTR], respectively). The ratio of RL to firefly
luciferase (FL) (encoded by an internal control reporter transcript
within the same plasmid) was set as one (‘‘1’’) for the parent
vector (psiCHECK2). The lower RL/FL ratios for HuD
siRNA-transfected cells (48%) relative to those for Ctrl
(legend on next page)
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siRNA-transfected cells indicated that the presence of APP 30
UTR reduced luciferase production when HuD was silenced
(Figure 1H, left). As shown in Figure 1H, right, there was a parallel
reduction in RL mRNA levels compared with FL mRNA levels
in HuD-silenced cells (52%), indicating that accelerated
decay of the RL-APP(30UTR) chimeric mRNA contributed to
the decrease in RL expression. In sum, HuD enhanced both
the stability and translation of APP mRNA.
HuD Stabilizes BACE1 mRNA and BACE1AS RNA
Next, we examined the interaction of HuD with BACE1
mRNA. HuD associated in vitro with partial biotinylated
segments of the 30 UTR but not the CR or 50 UTR of BACE1
mRNA, showing preferential binding to a distal BACE1 30 UTR
segment (30b) (Figures 2A and S2). The levels of BACE1
mRNA were lower in the HuD siRNA group, and this reduction
was achieved at least in part through a decline in BACE1
mRNA stability (Figures 2B and 2C), just as seen for APP
mRNA (Figure 1F); nontargets of HuD, including mRNAs encod-
ing g-secretases, did not show this trend (Figure S2). BACE1
protein levels were correspondingly lower, but the translation
of BACE1mRNA did not appear to be affected by HuD silencing
(Figures 2D and 2E).
The stability of BACE1 mRNA was not previously reported
to be affected by other RBPs, but it was shown to be stabilized
via interaction with the lncRNA BACE1AS (Faghihi et al., 2008).
Thus, we asked if the present regulatory paradigm involved
BACE1AS. RIP analysis revealed that BACE1AS was robustly
present in HuD RNP complexes (Figure 3A) and that HuD
associated in vitro with partial biotinylated segments of
BACE1AS RNA; negative controls GAPDH 30 UTR and the
lncRNA 7SL were included (Figure 3B). This interaction likely
stabilized BACE1AS because silencing HuD lowered the
steady-state levels (Figure 3C) and the t1/2 of BACE1AS (Fig-
ure 3D). Further evidence that BACE1 mRNA and BACE1AS
interacted in our study system was obtained by engineering
a plasmid that expressed a chimeric BACE1AS tagged
with MS2 RNA hairpins (pMS2-BACE1AS). By 36 hr after trans-
fecting SK-N-F1 cells with pMS2 or pMS2-BACE1AS along
with plasmid pMS2-YFP, which expressed a fluorescent fusion
protein, MS2-YFP (Lee et al., 2010; Figure 3E), RIP analysis
was carried out with anti-YFP to bring down the YFP-MS2
protein bound to MS2-bearing RNAs. As shown in Figure 3F,Figure 3. lncRNA BACE1AS Is the Target of HuD and BACE1 mRNA
(A) RIP analysis of the interaction of BACE1AS RNA with HuD.
(B) Schematic of human BACE1AS RNA, depicting the 50 and 30 segments (50
biotinylated BACE1AS RNA with HuD was assayed by biotin pull-down (biotinyla
GAPDH 30 UTR and 7SL were included as negative controls.
(C and D) Forty-eight hours after transfecting SK-N-F1 cells with the siRNAs indic
t1/2 of BACE1AS was quantified as in Figure 1F (D).
(E and F) SK-N-F1 cells were transfected with the plasmids shown (schematic). P
BACE1AS (expressing full-length BACE1AS) was cotransfected along with plas
MS2-tagged RNA) (E). By 24 hr after transfection of the plasmids in (E), lysates w
BACE1 mRNA in IP samples from each transfection group was assessed by RT-
(G) Schematic of proposed influence of HuD upon the expression and b-cleavage
translation. (2) HuD binds to BACE1 mRNA and stabilizes it. (3) HuD binds to BA
production. Arrowhead points to subsequent cleavage by g-secretase that relea
In (A), (C), (D), and (F), the graphs reflect the mean and SD from three independe
1406 Cell Reports 7, 1401–1409, June 12, 2014 ª2014 The AuthorsBACE1 mRNA, as measured by RT-qPCR analysis in the IP
samples, was significantly more abundant in MS2-BACE1AS
IP than in control IP (pMS2 transfection group), indicating that
BACE1 mRNA and BACE1AS associated physically in SK-N-
F1 cells.
Collectively, these results suggest a model whereby HuD
jointly controls three transcripts on the route to generating
amyloidogenic Ab: (1) HuD binds to APP mRNA and enhances
APP levels, (2) HuD binds to BACE1 mRNA and promotes
BACE1 production, and (3) HuD binds to BACE1AS RNA and
increases its levels, further augmenting BACE1 production. By
acting on functionally related RNAs, HuD serves as a master
coordinator of Ab production (Figure 3G).
HuD Influence on APP/Ab Production in the Brain
Based on the model proposed presented in Figure 3G, we
hypothesized that HuD may affect Ab production in the brain.
We tested this possibility using two different models. In trans-
genic mice overexpressing HuD (HuD-Tg mice) as a tagged
protein (Myc-HuD; Figure 4A), the levels of Ab40, as measured
by ELISA (Experimental Procedures), were significantly higher
than in WT mice (Figure 4B), and the levels of Elavl4 mRNA
(encoding HuD), App mRNA, Bace1 mRNA, and Bace1as RNA
were higher in hippocampus, cortex, and cerebellum, relative
to the levels in age-matched WT mice (Figure 4C).
We also studied the levels of HuD in the brains of patients with
AD. Brain sections from the superior temporal gyrus (STG) from
ten persons with AD and ten age-matched healthy individuals
were used for RNA and protein analysis. RNA prepared from
these samples was analyzed by RT-qPCR; as shown in Fig-
ure 4D, ELAVL4 mRNA and BACE1AS RNA were markedly
higher in AD brains relative to healthy brains, whereas APP
mRNA and BACE1 mRNA were moderately higher in patients
with AD. The relative levels of protein followed these general
differences (Figure 4E; Faghihi et al., 2008), with greater than
2-fold higher levels of HuD and BACE1 in AD brains. In keeping
with the higher levels of BACE1, Ab peptide (Ab40 and Ab42) was
also more abundant in AD brains (Figure 4F). In summary, in the
brains of HuD-overexpressing mice, the levels of APP, BACE1,
and Ab40 correlated with the heightened abundance of HuD,
whereas in human AD brains, HuD levels were significantly
elevated and correlated with higher levels of BACE1, BACE1AS,
and Ab.S and 30S) as well as the double-stranded (DS) segment. The interaction of
ted segments assayed are shown; gray underlines). FL, full-length BACE1AS.
ated, BACE1AS RNA levels were measured by RT-qPCR analysis (C), and the
lasmid pMS2, which expressed 24 repeats of MS2 hairpins, or plasmid pMS2-
mid pMS2-YFP (expressing a fusion protein [MS2-YFP] capable of detecting
ere subjected to RIP analysis using an antibody against YFP. The presence of
qPCR analysis (F).
of APP. (1) HuD binds toAPPmRNA and promotes APPmRNA stabilization and
CE1AS and stabilizes it, in turn increasing BACE1 mRNA stability and BACE1
ses Ab peptide (blue).
nt experiments. *p < 0.05.
(legend on next page)
Cell Reports 7, 1401–1409, June 12, 2014 ª2014 The Authors 1407
DISCUSSION
Our results indicate that HuD controls the expression of
three RNAs affecting APP production and processing into Ab.
The three-pronged actions of HuD include binding to APP
mRNA, causing it to be more stable and translated; binding
to BACE1 mRNA, increasing its stability and hence BACE1 pro-
duction; and binding to and stabilizing BACE1AS, which further
contributes to the production of BACE1. In keeping with this reg-
ulatory paradigm, HuD levels were positively linked to Ab levels
in three systems: in neuroblastoma SK-N-F1 cells expressing
normal versus silenced HuD levels, in the brains of WT and
HuD-overexpressingmice, and in the brains from AD and normal
subjects.
The discovery that HuD influences the production of the key
pathogenic peptide Ab raises the immediate question of what
determines the levels of HuD in neuronal tissues. Among the
possible transcriptional regulators of HuD expression is FoxO1;
the repression of ELAVL4 gene transcription in pancreatic b cells
was relieved by exposure to high glucose or insulin (Lee et al.,
2012). Whether FoxO1 also suppresses ELAVL4 gene transcrip-
tion in neuronal tissues and whether this regulation is dependent
on glucose/insulin await further study. Posttranscriptional regu-
lators of HuD production include the miRNA miR-375, which
binds to ELAVL4 mRNA, lowers its stability, and represses
HuD translation (Abdelmohsen et al., 2010; Supplemental
Discussion).
The notion that a single RBP, HuD, can jointly control the
expression of three transcripts (APP mRNA, BACE1 mRNA,
and BACE1AS RNA) that are functionally related supports the
‘‘posttranscriptional operon/regulon’’ model put forth by
Keene and Tenenbaum (2002). According to this model, a
single RBP can associate with and coordinate the expression
of multiple mRNAs that share a given RNA sequence with
affinity for the RBP and whose encoded gene products are
implicated in a specific cellular function. To establish a simple
analogy with a ‘‘transcriptional’’ operon/regulon, the RBP
functions as the equivalent of a transcription factor that
binds to a shared DNA sequence present in the promoter of
genes encoding proteins with related functions (as in eukary-
otes) or synthesizes a polycistronic RNA whose individual
RNA components encode proteins functionally linked. In light
of our findings, the traditional posttranscriptional operon/
regulon model would help to explain HuD function; we pro-
posed a slightly revised version of the model that includes non-
coding RNA.Figure 4. In Mice Overexpressing HuD, the Levels of AppmRNA, Bace1
Target Transcripts and Encoded Proteins, and Ab Are Elevated
(A) The levels of tagged HuD in whole-brain lysate frommice (three WT and three o
by WB analysis. Ponceau S staining was used to assess sample loading.
(B) ELISA was used to measure soluble Ab in WT and HuD-Tg (whole-brain lysat
(C) The levels of Elavl4mRNA (encoding HuD), AppmRNA, Bace1mRNA, and Ba
RT-qPCR; data were normalized to 18S rRNA.
(D and E) Lysates prepared from STG from normal subjects (n = 10) and from AD s
mRNA, and BACE1AS RNA using RT-qPCR (D) and for the encoded proteins (six
levels were normalized to GAPDH mRNA levels, protein levels to b-actin levels.
(F) The levels of Ab40 and Ab42 were assayed in ten normal and ten AD brains (S
In (B)–(F), the graphs reflect the mean and SD from three independent experime
1408 Cell Reports 7, 1401–1409, June 12, 2014 ª2014 The AuthorsOur studies did not identify a specific RNA element present in
the three transcripts. However, most RBPs do not have strict
sequence requirements and instead associate with loosely vari-
able RNA elements, often within the context of a given secondary
structure. Approaches such as photoactivatable-ribonucleo-
side-enhanced crosslinking and IP identification of HuD-bound
RNAs can give us a more precise view of the subset of tran-
scripts with which HuD interacts. A more complete understand-
ing of the collection of HuD-interacting coding and noncoding
RNAs will be particularly informative as we strive to understand
the underlying causes of Ab processing in AD.
EXPERIMENTAL PROCEDURES
Cell Culture, siRNA, and Plasmids
Human neuroblastoma SK-N-F1 cells were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 10% (v/v) fetal bovine serum
and antibiotics. The plasmids and siRNAs used are described in Supplemental
Experimental Procedures.
Protein Analysis
WBanalysis and fractionation of polyribosomes are explained in Supplemental
Experimental Procedures. Ab levels (Ab40 and Ab42) in SK-N-F1 cells were
measured in conditioned media, and Ab in human brain samples was assayed
directly from protein lysates. Human Ab was measured by ELISA (Invitrogen;
KHB3481 and KHB3441), and the manufacturer’s protocol included incuba-
tion with guanidine; [methyl(phenyl)-l3-oxidanyl]formic acid solution. Ab levels
in mouse brain lysates were analyzed by ELISA (Invitrogen).
RNA Analysis
RNA-binding assays RIP (RNP IP) and biotin pull-down, as well as mRNA t1/2
measurements, are explained in Supplemental Experimental Procedures.
TRIzol (Invitrogen) was used to extract total RNA, and acidic phenol (Ambion)
was used to extract RNA for RIP analysis (Lee et al., 2010). RT was performed
using random hexamers and Maxima Reverse Transcriptase (Thermo Scienti-
fic), and real-time qPCR was done using gene-specific primers (Supplemental
Experimental Procedures). RT-qPCR was performed using SYBR Green
Master Mix (Kapa Biosystems) in an Applied Biosystems 7300 instrument.
Human Subjects
The sample consists of 20 participants (19 females and 1 male) from the
Baltimore Longitudinal Study of Aging (BLSA) (National Institute on Aging
[NIA], National Institutes of Health); cognitive status was determined based
on standardized consensus diagnostic procedures for the BLSA (Driscoll
et al., 2012) and eventually came to autopsy. Participants were between 55
and 98 (AD) and 56 and 95 (normal) years of age. All studies were approved
by the local institutional review boards, and all participants gave written
informed consent prior to each assessment. In addition, next of kin or legally
designated power of attorney provided consent for autopsy. STG regions of
the brain were used for protein and RNA analysis.mRNA, Bace1as RNA, and Ab Are Elevated; in AD Brains, HuD, HuD
verexpressing the Myc-HuD transgene [9-month-old females]) were assessed
es; three mice per genotype).
ce1as in each mouse brain group (n = 3 mice per genotype) were measured by
ubjects (n = 10) were assayed for levels of ELAVL4mRNA, APPmRNA, BACE1
normal, seven AD) by WB analysis followed by densitometric analysis (E). RNA
TG) by using ELISA.
nts. p values are indicated in (D) and (E). *p < 0.05.
Animals
HuD-Tg (Bolognani et al., 2010; a kind gift fromDr. N.I. Perrone-Bizzozero) and
WT mice in the C57BL/6J background were obtained from in-house breeding
colonies of the NIA (Baltimore) (details are provided in Supplemental Experi-
mental Procedures).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Discussion, Supplemental Experimental Procedures, and two figures and
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